Back to search results

Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD

Abroad (travel likely)RecruitingPHASE1

Conditions

Alzheimer Disease, Early Onset · Mild Cognitive Impairment · Moderate Dementia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Cedars-Sinai Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Sandra Gomez, MD) · Sandra.Gomez3@cshs.org · (424) 315-1224
    Contact: Principal Investigator (Sara Espinoza, MD)
    Nicolas Musi, MD (Sub-investigator)

  • Memory and Aging Program, Butler Hospital, Providence, Rhode Island, United States

    Contact: Study coordinator (Meghan Riddle, MD) · MRiddle@butler.org · 401 455-6403
    Contact: Study coordinator (Denise Jerue, RN) · DJerue@butler.org · 401 455-6403
Study leads

  • Meghan Riddle, MD

    Principal Investigator

    Butler Hospital

  • John Sedivy, PhD

    Principal Investigator

    Brown University

View source on ClinicalTrials.gov(opens in a new tab)